Elutia Inc. Class A Common Stock (ELUT) is a publicly traded Healthcare sector company. As of May 21, 2026, ELUT trades at $1.18 with a market cap of $48.63M and a P/E ratio of 0.91. ELUT moved +6.70% today. Year to date, ELUT is +92.18%; over the trailing twelve months it is -35.16%. Its 52-week range spans $0.50 to $5.12. Analyst consensus is buy with an average price target of $5.00. Rallies surfaces ELUT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ELUT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.18 |
| Market Cap | $48.63M |
| P/E Ratio | 0.91 |
| EPS | $1.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.12 |
| 52-Week Low | $0.50 |
| Volume | 758 |
| Avg Volume | 0 |
| Revenue (TTM) | $12.29M |
| Net Income | $53.38M |
| Gross Margin | 53.66% |
1 analysts cover ELUT: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.00.